Navamedic ASA has entered into a Share Purchase Agreement to acquire 100% of the shares in Novicus Pharma AS. The acquisition will strengthen Navamedics executive team, product pipeline and network in the pharma industry. As part of the proposed transaction, the three founders of Novicus Pharma have agreed to become key members of the Navamedic management team including Kathrine Gamborg Andreassen as CEO of Navamedic, Ole Henrik Eriksen as COO and Astrid T Bratvedt as Vice President of R&D.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
34.1 NOK | +0.59% | -3.40% | -7.08% |
05-06 | Navamedic Rolls Out Erectile Dysfunction Drug in Sweden | MT |
04-30 | Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.08% | 56.39M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.38% | 238B | |
+7.09% | 204B | |
-6.38% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- NAVA Stock
- News Navamedic ASA
- Navamedic ASA Announces Management Appointments